Please note that there is no central postal address for the Institute of Pharmacy. Please use the individual addresses found on the pages of the different sections.
Prof. Dr. Oliver Werz investigates mechanisms of action and targets of anti-inflammatory and anti-neoplastic compounds at the molecular and cellular level. In addition, Prof. Werz is searching for new therapeutic drugs for the treatment of inflammations, autoimmune diseases, neurodegenerative diseases and tumors. An important aspect of the research is gender-specific differences in pharmacotherapy (“gender medicine”).
Prof. Dr. Gerhard Scriba develops highly specialized, modern analytical separation techniques, particularly for purity testing of pharmaceutical drugs. The research includes the development of new methods for the separation of stereoisomers, mechanistic examination of the interaction between analyte and selector and the development of capillary electrophoresis-based enzyme assays.
Research in Prof. Dirk Hoffmeister's group focuses on basidiomycete natural products. The research aims at elucidation of biosyntheses and biotechnological production of bioactive compounds, along with the function of the compounds for their producers.
Prof. Dr. Thomas Winckler is interested to uncover the molecular mechanisms that certain mobile genetic elements use to identify specific integration sites in the genome of the "social amoeba" Dictyostelium discoideum. The pharmaceutical perspective of this research is to improve current retroviral gene therapy vectors with a component that may help reduce the genotoxicity of such vectors. In another research field Prof. Winckler is interested to determine how individual cells of social amoeba communicate with each other during the aggregation of single cells into multicellular organisms that later form fruiting bodies. Finally, Prof. Winckler is using cell-based and other assays to uncover new lead structures as NMDA receptor antagonists that may be useful as drugs for the therapy of Alzheimer´s disease.